AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 805402 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 276
Study 11963345 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselling session integrating supportive, educational and cognitive‐behavioral components
Number of subjects: 859
Study 11963345 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visits program (5 to 8 visits)
Number of subjects: 859
Study 30922849 — intervention group
Group type: EXPERIMENTAL
Intervention: Fire-needle acupuncture group (FAG)
Number of subjects: 120
Study 30922849 — intervention group
Group type: COMPARATOR
Intervention: Filiform-needle acupuncture group (FFAG)
Number of subjects: 120
Study 30922849 — intervention group
Group type: COMPARATOR
Intervention: Rehabilitation treatment group (RTG)
Number of subjects: 120
Study 30096441 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication reminder and symptom management intervention (automated system calling daily for medication reminders and weekly for symptom assessment)
Number of subjects: 272
Study 30096441 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 272
Study 26655583 — intervention group
Group type: EXPERIMENTAL
Intervention: Agomelatine
Number of subjects: 25
Study 26655583 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 24835901 — intervention group
Group type: EXPERIMENTAL
Intervention: Mastoid dressing (n=17)
Number of subjects: 37
Study 24835901 — intervention group
Group type: COMPARATOR
Intervention: Non-mastoid dressing (n=20)
Number of subjects: 37
Study 24835901 — intervention group
Group type: EXPERIMENTAL
Intervention: Mastoid dressing
Number of subjects: 37
Study 24835901 — intervention group
Group type: COMPARATOR
Intervention: Non-mastoid dressing
Number of subjects: 37
Study 23116213 — intervention group
Group type: COMPARATOR
Intervention: NHS Health Check service only
Number of subjects: 601
Study 23116213 — intervention group
Group type: EXPERIMENTAL
Intervention: NHS Health Check service plus additional lifestyle support
Number of subjects: 601
Study 20157024 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D prosthetic mimics of lesions and eruptions
Number of subjects: 90
Study 20157024 — intervention group
Group type: COMPARATOR
Intervention: 2D images
Number of subjects: 90
Study 18728372 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin treatment
Number of subjects: 198
Study 18728372 — intervention group
Group type: COMPARATOR
Intervention: No aspirin treatment (Control)
Number of subjects: 198
Study 18728372 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin treatment (before and after)
Number of subjects: 198
Study 18728372 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin-resistant group
Number of subjects: 198
Study 16296923 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct Vision (DV) training
Number of subjects: 7
Study 16296923 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic digital gas‐discharge visualization (GDV) bioelectrography
Number of subjects: 7
Study 11889662 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 18
Study 11889662 — intervention group
Group type: COMPARATOR
Intervention: Sham Acupuncture
Number of subjects: 18
Study 11889662 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Acupuncture and Sham Acupuncture)
Number of subjects: 18
Study 9697788 — intervention group
Group type: EXPERIMENTAL
Intervention: PSA corrected for total prostate volume (PSA-D)
Number of subjects: 1202
Study 9697788 — intervention group
Group type: EXPERIMENTAL
Intervention: PSA corrected for transition zone volume (PSA-T)
Number of subjects: 1202
Study 9697788 — intervention group
Group type: COMPARATOR
Intervention: PSA alone
Number of subjects: 1202
Study 8563871 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 mg/kg prednisolone daily
Number of subjects: 24
Study 8563871 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 mg/kg prednisolone daily
Number of subjects: 24
Study 8563871 — intervention group
Group type: EXPERIMENTAL
Intervention: megadose pulsed steroid therapy (500 or 1000 mg hydrocortisone-21-sodium succinate or methylprednisolone intravenously once a day)
Number of subjects: 24
Study 2514981 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose L-deprenyl (up to 40 mg/day)
Number of subjects: 12
Study 2514981 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional doses of deprenyl (10 mg/day)
Number of subjects: 12
Study 2514981 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 335093 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose terbutaline sulfate (1.5 mg)
Number of subjects: 25
Study 335093 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose terbutaline sulfate (0.75 mg)
Number of subjects: 25
Study 335093 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoproterenol (0.3 mg)
Number of subjects: 25
Study 335093 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 31608822 — intervention group
Group type: EXPERIMENTAL
Intervention: Information about childhood trauma history (interpersonal)
Number of subjects: 461
Study 31608822 — intervention group
Group type: EXPERIMENTAL
Intervention: Information about childhood trauma history (non-interpersonal)
Number of subjects: 461
Study 31608822 — intervention group
Group type: EXPERIMENTAL
Intervention: Information about childhood trauma history
Number of subjects: 461
Study 31608822 — intervention group
Group type: EXPERIMENTAL
Intervention: Contextual information about pregnancy status (pregnant)
Number of subjects: 461
Study 31655410 — intervention group
Group type: EXPERIMENTAL
Intervention: rBoNT-E (0.04-3.6 ng)
Number of subjects: 52
Study 31655410 — intervention group
Group type: COMPARATOR
Intervention: abobotulinumtoxinA (20, 40, or 70 U)
Number of subjects: 52
Study 27427555 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-energy shock-wave therapy (LESWT)
Number of subjects: 42
Study 27427555 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone marrow-derived mesenchymal stem cell (BMSC) transplantation
Number of subjects: 42
Study 27427555 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of LESWT and BMSC transplantation
Number of subjects: 42
Study 27427555 — intervention group
Group type: COMPARATOR
Intervention: Control group (Diabetic group)
Number of subjects: 42
Study 26011919 — intervention group
Group type: COMPARATOR
Intervention: Dieting (reduced daily intake by 500 kilocalories)
Number of subjects: 80
Study 26011919 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (moderate-intensity aerobic and resistance exercise, 200-300 min/week)
Number of subjects: 80
Study 23065432 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended daily hemodialysis (EHD)
Number of subjects: 407
Study 23065432 — intervention group
Group type: COMPARATOR
Intervention: High volume peritoneal dialysis (HVPD)
Number of subjects: 407
Study 21777452 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Toddlers intervention (eight in-home lessons and four reinforcement telephone contacts)
Number of subjects: 0
Study 21777452 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Toddlers intervention
Number of subjects: 0
Study 18280767 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral manipulation of talocrural joints (n=32)
Number of subjects: 62
Study 18280767 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=30)
Number of subjects: 62
Study 16624773 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural morphine 4 mg before operation and 80 microg/h for 48 h after operation
Number of subjects: 40
Study 16624773 — intervention group
Group type: COMPARATOR
Intervention: Epidural injection of normal saline before operation and 0.15% ropivacaine 2.0 ml/h for 48 h after operation
Number of subjects: 40
Study 13680104 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfix and periosteal flap
Number of subjects: 41
Study 13680104 — intervention group
Group type: COMPARATOR
Intervention: Transfix and resorbable screw
Number of subjects: 41
Study 11411461 — intervention group
Group type: EXPERIMENTAL
Intervention: D,L-fenfluramine (100 mg po)
Number of subjects: 109
Study 11411461 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109
Study 9236426 — intervention group
Group type: EXPERIMENTAL
Intervention: Early angiography and revascularization (angioplasty or bypass surgery) within 24 hours of shock onset
Number of subjects: 2200
Study 9236426 — intervention group
Group type: COMPARATOR
Intervention: No early angiography and revascularization
Number of subjects: 2200
Study 9236426 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive strategy of early angiography
Number of subjects: 2200
Study 7962283 — intervention group
Group type: EXPERIMENTAL
Intervention: alpha-methyl-para-tyrosine (AMPT)
Number of subjects: 7
Study 7962283 — intervention group
Group type: COMPARATOR
Intervention: promethazine (control)
Number of subjects: 7
Study 2890525 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl analgesia
Number of subjects: 1600
Study 2890525 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil analgesia
Number of subjects: 1600
Study 30504404 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery plus neoadjuvant radiochemotherapy
Number of subjects: 52
Study 30504404 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 52
Study 26866979 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-day dolutegravir functional monotherapy
Number of subjects: 28
Study 26866979 — intervention group
Group type: COMPARATOR
Intervention: 7-day placebo
Number of subjects: 28
Study 24739083 — intervention group
Group type: EXPERIMENTAL
Intervention: Ice skating (8 sessions during education lessons)
Number of subjects: 30
Study 24739083 — intervention group
Group type: COMPARATOR
Intervention: Normal physical education (control group)
Number of subjects: 30
Study 23357764 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftaroline fosamil (1,500 mg)
Number of subjects: 54
Study 23357764 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin (400 mg)
Number of subjects: 54
Study 23357764 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 20447934 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposed to smoking (1 cigarette)
Number of subjects: 41
Study 20447934 — intervention group
Group type: COMPARATOR
Intervention: Unexposed control (time-lapse equivalent)
Number of subjects: 41
Study 18166815 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (1 g twice daily)
Number of subjects: 96
Study 18166815 — intervention group
Group type: COMPARATOR
Intervention: Repaglinide (2 mg thrice daily)
Number of subjects: 96
Study 15781543 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mL of 15% magnesium sulfate (12.4 mmol) plus 3 mg/kg lidocaine 0.5% diluted with saline to a total of 40 mL in group M
Number of subjects: 30
Study 15781543 — intervention group
Group type: COMPARATOR
Intervention: 10 mL of saline plus 3 mg/kg lidocaine 0.5% diluted with saline to a total of 40 mL in group C
Number of subjects: 30
Study 14632754 — intervention group
Group type: EXPERIMENTAL
Intervention: Thymosin alpha 1 (3.2 mg subcutaneous injections twice weekly for 12 weeks)
Number of subjects: 20
Study 14632754 — intervention group
Group type: COMPARATOR
Intervention: Control (no injections for 12 weeks)
Number of subjects: 20
Study 10573277 — intervention group
Group type: EXPERIMENTAL
Intervention: ILIAD (version 4.2)
Number of subjects: 216
Study 10573277 — intervention group
Group type: EXPERIMENTAL
Intervention: Quick Medical Reference (QMR; version 3.7.1)
Number of subjects: 216
Study 8721025 — intervention group
Group type: EXPERIMENTAL
Intervention: rHuEPO at a dose of 150 IU/L
Number of subjects: 15
Study 8721025 — intervention group
Group type: EXPERIMENTAL
Intervention: rHuEPO at a dose of 250 IU/L
Number of subjects: 15
Study 8721025 — intervention group
Group type: EXPERIMENTAL
Intervention: rHuEPO at a dose of 400 IU/L
Number of subjects: 15
Study 8721025 — intervention group
Group type: EXPERIMENTAL
Intervention: rHuEPO treatment
Number of subjects: 15
Study 8721025 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial EPO levels < 100 IU/L
Number of subjects: 15
Study 8721025 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial EPO levels > 100 IU/L
Number of subjects: 15
Study 8721025 — intervention group
Group type: EXPERIMENTAL
Intervention: rHuEPO
Number of subjects: 15
Study 1760823 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow-release isosorbide-5-mononitrate (IS-5-MN), 25 mg once daily
Number of subjects: 30
Study 1760823 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupranolol, 50 mg once daily
Number of subjects: 30
Study 1760823 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of IS-5-MN and bupranolol
Number of subjects: 30
Study 1760823 — intervention group
Group type: EXPERIMENTAL
Intervention: Both drugs (IS-5-MN and bupranolol)
Number of subjects: 30
Study 6123810 — intervention group
Group type: EXPERIMENTAL
Intervention: Clobazam (20 mg or 30 mg per day)
Number of subjects: 18
Study 6123810 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 31784436 — intervention group
Group type: EXPERIMENTAL
Intervention: L2B Plus (Learning to BREATHE plus ecological momentary intervention)
Number of subjects: 38
Study 31784436 — intervention group
Group type: COMPARATOR
Intervention: Active health and wellness control condition
Number of subjects: 38
Study 30284172 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality improvement intervention consisting of a personalized decision support tool, educational program, performance measure, and audit and feedback system.
Number of subjects: 3787
Study 30284172 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality improvement intervention ended.
Number of subjects: 3787
Study 26931572 — intervention group
Group type: EXPERIMENTAL
Intervention: Violence prevention intervention (community conversations and planning focused on enhancing the value of girls in the community)
Number of subjects: 6000
Study 26931572 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention (cash transfer to the household conditioned on school enrollment and attendance)
Number of subjects: 6000
Study 26931572 — intervention group
Group type: EXPERIMENTAL
Intervention: Health intervention (culturally relevant, age-appropriate sexual and reproductive health education delivered in a group setting once a week for 2 years)
Number of subjects: 6000
Study 26931572 — intervention group
Group type: EXPERIMENTAL
Intervention: Wealth creation intervention (savings and financial education, as well as start-up savings)
Number of subjects: 6000
Study 24118351 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-wavelength laser system treatment (pulsed dye laser and Nd:YAG)
Number of subjects: 12
Study 22364209 — intervention group
Group type: EXPERIMENTAL
Intervention: Intimate Partner Violence (IPV)
Number of subjects: 343
Study 19434815 — intervention group
Group type: EXPERIMENTAL
Intervention: Levamisole plus colchicine
Number of subjects: 64
Study 19434815 — intervention group
Group type: COMPARATOR
Intervention: Normal control subjects
Number of subjects: 64
Study 17880351 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief motivational intervention (BMI) with 2 sessions
Number of subjects: 539
Study 17880351 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 539
Study 15447921 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation
Number of subjects: 745
Study 15447921 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dairy product consumption
Number of subjects: 745
Study 15447921 — intervention group
Group type: COMPARATOR
Intervention: Calcium intake
Number of subjects: 745
Study 11515644 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass-ionomer sealant (Fuji III)
Number of subjects: 179
Study 11515644 — intervention group
Group type: COMPARATOR
Intervention: Resin-based sealant (Delton)
Number of subjects: 179
Study 9609894 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid meal (5 mg per kilogram of body weight)
Number of subjects: 14
Study 9609894 — intervention group
Group type: COMPARATOR
Intervention: No meal (control group)
Number of subjects: 14
Study 7824868 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy
Number of subjects: 72
Study 7824868 — intervention group
Group type: COMPARATOR
Intervention: Conventional cholecystectomy
Number of subjects: 72
Study 2970080 — intervention group
Group type: EXPERIMENTAL
Intervention: Y connection system (Group IA)
Number of subjects: 126
Study 2970080 — intervention group
Group type: COMPARATOR
Intervention: Conventional technique (Group IB)
Number of subjects: 126
Study 2970080 — intervention group
Group type: EXPERIMENTAL
Intervention: Y connection system (Group II)
Number of subjects: 126
Study 2970080 — intervention group
Group type: COMPARATOR
Intervention: Conventional technique (Group III)
Number of subjects: 126
Study 1958910 — intervention group
Group type: EXPERIMENTAL
Intervention: Pay group (user fees)
Number of subjects: 59
Study 1958910 — intervention group
Group type: COMPARATOR
Intervention: No pay group (no user fees)
Number of subjects: 59
Study 1958910 — intervention group
Group type: COMPARATOR
Intervention: Both groups (pay and no pay)
Number of subjects: 59
Study 340136 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg atenolol
Number of subjects: 98
Study 340136 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg atenolol
Number of subjects: 98
Study 340136 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg atenolol
Number of subjects: 98
Study 340136 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study 30187641 — intervention group
Group type: EXPERIMENTAL
Intervention: ILM peeling of 2DD
Number of subjects: 121
Study 30187641 — intervention group
Group type: EXPERIMENTAL
Intervention: ILM peeling of 4DD
Number of subjects: 121
Study 30187641 — intervention group
Group type: EXPERIMENTAL
Intervention: MHCI ≤0.5
Number of subjects: 121
Study 30187641 — intervention group
Group type: EXPERIMENTAL
Intervention: MHCI >0.5
Number of subjects: 121
Study 28611007 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored intervention
Number of subjects: 450
Study 28611007 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted intervention
Number of subjects: 450
Study 28611007 — intervention group
Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 450
Study 28611007 — intervention group
Group type: EXPERIMENTAL
Intervention: Achieving 5% weight loss
Number of subjects: 450
Study 26163302 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness bibliotherapy
Number of subjects: 90
Study 26163302 — intervention group
Group type: COMPARATOR
Intervention: Progressive Muscle Relaxation (PMR)
Number of subjects: 90
Study 23543129 — intervention group
Group type: COMPARATOR
Intervention: NYHA class III
Number of subjects: 405
Study 23543129 — intervention group
Group type: EXPERIMENTAL
Intervention: NYHA class IV
Number of subjects: 405
Study 21376161 — intervention group
Group type: EXPERIMENTAL
Intervention: 17-hydroxyprogesterone caproate (17Pc), 250 mg weekly injections starting at 16-24 weeks until 34 weeks
Number of subjects: 240
Study 21376161 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study 21376161 — intervention group
Group type: EXPERIMENTAL
Intervention: 17-hydroxyprogesterone caproate (17Pc)
Number of subjects: 240
Study 19236894 — intervention group
Group type: EXPERIMENTAL
Intervention: Play equipment provided
Number of subjects: 583
Study 19236894 — intervention group
Group type: EXPERIMENTAL
Intervention: Markings painted on the playground
Number of subjects: 583
Study 19236894 — intervention group
Group type: EXPERIMENTAL
Intervention: Play equipment provided and markings painted
Number of subjects: 583
Study 19236894 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no intervention)
Number of subjects: 583
Study 17429083 — intervention group
Group type: EXPERIMENTAL
Intervention: Anakinra (100 mg subcutaneously once daily for 13 weeks)
Number of subjects: 70
Study 17429083 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 15976592 — intervention group
Group type: EXPERIMENTAL
Intervention: Rigid lens (Z-alpha, Menicon Co. Ltd.)
Number of subjects: 100
Study 15976592 — intervention group
Group type: COMPARATOR
Intervention: Soft lens (Focus Night & Day, Ciba Vision)
Number of subjects: 100
Study 15976592 — intervention group
Group type: EXPERIMENTAL
Intervention: Both lens types
Number of subjects: 100
Study 11689580 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin alfa 150 IU/kg subcutaneously three times per week, doubled after 4 weeks for non-responders
Number of subjects: 401
Study 9394855 — intervention group
Group type: EXPERIMENTAL
Intervention: Anastrozole 1 mg once daily
Number of subjects: 0
Study 9394855 — intervention group
Group type: EXPERIMENTAL
Intervention: Anastrozole 10 mg once daily
Number of subjects: 0
Study 9394855 — intervention group
Group type: COMPARATOR
Intervention: Megestrol acetate 40 mg q.i.d.
Number of subjects: 0
Study 7934116 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicaval anastomoses
Number of subjects: 18
Study 7934116 — intervention group
Group type: COMPARATOR
Intervention: Atrial anastomoses
Number of subjects: 18
Study 3354875 — intervention group
Group type: COMPARATOR
Intervention: Aerosolized lidocaine and IV saline
Number of subjects: 40
Study 3354875 — intervention group
Group type: COMPARATOR
Intervention: Aerosolized saline and IV lidocaine
Number of subjects: 40
Study 3354875 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosolized lidocaine and IV lidocaine
Number of subjects: 40
Study 30313028 — intervention group
Group type: EXPERIMENTAL
Intervention: LED therapy with phototherapy sessions
Number of subjects: 100
Study 30313028 — intervention group
Group type: COMPARATOR
Intervention: Orientation regarding breast care and adequate breastfeeding techniques (Control)
Number of subjects: 100
Study 29175809 — intervention group
Group type: EXPERIMENTAL
Intervention: Agoraphobia Free mobile app
Number of subjects: 170
Study 29175809 — intervention group
Group type: COMPARATOR
Intervention: Stress Free mobile app
Number of subjects: 170
Study 26288120 — intervention group
Group type: EXPERIMENTAL
Intervention: High-speed gait training with HAL (20min/session, once a week for 8 weeks)
Number of subjects: 18
Study 26288120 — intervention group
Group type: COMPARATOR
Intervention: Conventional physical therapy
Number of subjects: 18
Study 23704845 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally adapted dietary approach and exercise program, delivered through 24 group sessions, with daily food intake and physical activity recording.
Number of subjects: 223
Study 23704845 — intervention group
Group type: COMPARATOR
Intervention: Usual care (referral to a dietitian).
Number of subjects: 223